NewEdge Wealth LLC Takes Position in National Health Investors, Inc. $NHI

NewEdge Wealth LLC bought a new position in shares of National Health Investors, Inc. (NYSE:NHI) in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 29,178 shares of the real estate investment trust’s stock, valued at approximately $2,225,000.

A number of other institutional investors have also made changes to their positions in NHI. NewEdge Advisors LLC raised its stake in National Health Investors by 28.7% in the 1st quarter. NewEdge Advisors LLC now owns 1,546 shares of the real estate investment trust’s stock valued at $114,000 after acquiring an additional 345 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its position in National Health Investors by 9.6% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 249,937 shares of the real estate investment trust’s stock worth $18,460,000 after purchasing an additional 21,851 shares during the period. Jane Street Group LLC increased its holdings in shares of National Health Investors by 1,728.4% in the first quarter. Jane Street Group LLC now owns 69,697 shares of the real estate investment trust’s stock valued at $5,148,000 after purchasing an additional 65,885 shares during the last quarter. Cetera Investment Advisers increased its holdings in shares of National Health Investors by 6.1% in the second quarter. Cetera Investment Advisers now owns 4,792 shares of the real estate investment trust’s stock valued at $336,000 after purchasing an additional 275 shares during the last quarter. Finally, American Century Companies Inc. lifted its stake in shares of National Health Investors by 2.2% during the 2nd quarter. American Century Companies Inc. now owns 19,236 shares of the real estate investment trust’s stock worth $1,349,000 after buying an additional 420 shares during the last quarter. 62.51% of the stock is owned by institutional investors and hedge funds.

National Health Investors Stock Performance

Shares of NYSE:NHI opened at $73.91 on Friday. National Health Investors, Inc. has a 12-month low of $67.94 and a 12-month high of $91.38. The company’s 50 day moving average price is $75.45 and its two-hundred day moving average price is $79.13. The firm has a market cap of $3.63 billion, a PE ratio of 21.36, a PEG ratio of 3.40 and a beta of 0.51. The company has a quick ratio of 6.78, a current ratio of 6.78 and a debt-to-equity ratio of 0.81.

National Health Investors (NYSE:NHI) last released its quarterly earnings results on Monday, August 10th. The real estate investment trust reported $1.19 earnings per share for the quarter. The company had revenue of $121.32 million during the quarter. National Health Investors had a net margin of 38.56% and a return on equity of 10.89%. The firm’s quarterly revenue was up 1.6% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.22 earnings per share. National Health Investors has set its FY 2026 guidance at 4.740-4.790 EPS. Equities research analysts predict that National Health Investors, Inc. will post 4.77 earnings per share for the current year.

National Health Investors Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 6th. Shareholders of record on Wednesday, September 30th will be issued a $0.92 dividend. The ex-dividend date of this dividend is Wednesday, September 30th. This represents a $3.68 annualized dividend and a yield of 5.0%. National Health Investors’s payout ratio is currently 108.67%.

Insider Buying and Selling at National Health Investors

In related news, Director Robert A. Mccabe, Jr. bought 890 shares of the business’s stock in a transaction dated Monday, June 15th. The stock was purchased at an average cost of $71.65 per share, for a total transaction of $63,768.50. Following the transaction, the director owned 44,159 shares in the company, valued at $3,163,992.35. The trade was a 2.06% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO D. Eric Mendelsohn bought 1,500 shares of National Health Investors stock in a transaction dated Friday, June 5th. The shares were bought at an average cost of $68.84 per share, for a total transaction of $103,260.00. Following the completion of the acquisition, the chief executive officer owned 133,316 shares in the company, valued at $9,177,473.44. This represents a 1.14% increase in their position. The SEC filing for this purchase provides additional information. 2.70% of the stock is owned by insiders.

Wall Street Analyst Weigh In

Several analysts recently commented on NHI shares. BMO Capital Markets reduced their target price on shares of National Health Investors from $90.00 to $80.00 and set an “outperform” rating for the company in a report on Monday, June 15th. Truist Financial cut their price objective on shares of National Health Investors from $89.00 to $81.00 and set a “buy” rating for the company in a research report on Friday, June 12th. Deutsche Bank Aktiengesellschaft reduced their price objective on National Health Investors from $85.00 to $80.00 and set a “hold” rating for the company in a report on Thursday, June 25th. Zacks Research lowered National Health Investors from a “hold” rating to a “strong sell” rating in a research note on Thursday, June 25th. Finally, Wells Fargo & Company dropped their price target on National Health Investors from $84.00 to $79.00 and set an “equal weight” rating for the company in a report on Monday, June 1st. Five investment analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $83.86.

National Health Investors Profile

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.